ADP receptor inhibitor

This page covers all ADP receptor inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting P2Y12.

Targets

P2Y12

Phase 2 pipeline (1)

• ADP receptor inhibitors · Eli Lilly and Company · Cardiovascular
  ADP receptor inhibitors block the action of ADP on its receptor, preventing platelet activation and aggregation.